The in hospital mortality rate after myocardial infarction is higher among women than men. PCI is recommended treatment for ST -segment elevation myocardial infarction (STEMI) in patients of both genders. It is used in women without a clear demonstration of their efficiency in this population. It is only extrapolations of studies enrolling a large majority of males (more than 85%).It is very important to improve our therapeutic straté-gies in women, to perform dedicated studies.
Background: It has been shown that elevated blood glucose levels on admission are associated with worse outcome in ST elevation myocardial infarction.
Impaired microvascular function and no-reflow phenomenon seem to be one of the underlying mechanisms of hyperglycemia deleterious effects Aim: To establish the relationship between hyperglycemia on admission and the no-reflow phenomenon Methods: Patients presenting with acute STEMI who underwent primary percutaneous coronary intervention (PCI) were enrolled. ST segment resolution was evaluated at 90 minutes in the worst lead. No-reflow was defined as a resolution of ST segment less than 50% in the worst lead at 90 minutes Results: 102 consecutive patients were enrolled (87 men and 15 women) with a mean age of 56.95 ±12.89 years. The no-reflow phenomenon was observed in 28 (27.45 %) patients, their glucose level on hospital admission was significantly higher than in patients whithout no-reflow phenomenon (12.48 ± 7.48 vs. 8.55 ± 2.27 mmol/l; p = 0.01). Multivariate analysis showed that hyperglycemia defined as glycemia >11mmol/L was an independent predictor factor for no-reflow (OR = 2.18, CI = 1.42 -3.84; p = 0.002) Conclusion: Hyperglycemia on admission is associated with higher risk of no-reflow in STEMI patients undergoing primary PCI.
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Relationship between balloon release pressure and ST resolution in STEMI patients undergoing primary PCI Ouafa Hamza, Omar Ait Mokhtar, Abdelmalek Azzouz, Nabil Bendaoud, Mourad Saidane, Samia Latrèche, Khereddine Merad, Salim Benkhedda CHU Mustapha, Cardiologie A2, Alger, Algérie Background: The optimal balloon release pressure in primary percutaneous coronary intervention is not well established and use of high pressure may jeopardize ST resolution and increase the occurrence of no reflow.
Aim:
To investigate the relationship between balloon release pressure and ST resolution in STEMI patients undergoing primary PCI.
Methods:
Patients undergoing primary PCI for ST elevation myocardial infarction were enrolled and assigned into two groups according to the stent implantation pressure. High pressure group with a pressure >16 atm. Standard pressure <16 atm. The balloon pressure release was left to the operators' discretion. No-reflow phenomenon was defined as Σ ST-segment resolution <70%
Results: 137 patients were enrolled with a mean age of 56.39 ± 12.8 years.
The results showed that no-reflow phenomenon occurred more frequently in the high pressure group 49.32% vs 27%; p = 0.002. Furthermore, the high pressure group showed less ST resolution than the low pressure group with a mean ST-resolution 60.43 ± 25.86 vs 72.35 ± 18.13; p = 0.001
Conclusion:
In primary PCI when stenting the culprit lesion, low pressure release may be better in avoiding the no reflow phenomenon
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Prevalence of glucose disoders in a cohort of patients hospitalized for ACS in coronary care unit, and security and efficiency of an intraveinous insulin protocol adapted on glycemic kinetic Emilie Kamaryk (1), Arsène Monnier (2), Fabienne Amiot Chapoutot (3), Aurélie Marchais (1), Laurent Chapoutot (1), Pierre Nazeyrollas (2) (1) CH Troyes, Cardiologie, Troyes, CHU Reims, Hôpital Robert Debré, Cardiologie, Reims, CH Troyes, Diabétologie, Troyes, France Background: Glycemic variabilities have a negative impact on the morbidity and mortality of acute coronary syndromes (ACS). A strict glucose monitoring is recommended on admission in Coronary Care Unit (CCU). The aims of our study were to assess the prevalence of various glucose disorders (diabete mellitus, impared fasting hyperglycemia, glucose intolerance, stress hyperglycemia) among patients hospitalized for ACS, and to assess the efficency and security of an IV insulin protocol adapted on glycemic kinetic, to decrease the risk of hypoglycemia, and for which the goal was to stabilized glycemia between 1.10 and 1,40g/l.
Population and Method:
This retrospective monocenter study concerns all patients admitted for ACS (STEMI and NSTEMI) in Troyes hospital from May 2012 to May 2013. The different glycemic parameters, capillarious and veinous were collect through analysis of medical reports.
Results: 164 patients were included. The mean age was 65 ± 13 years. Among them, 97 (59%) had diabete mellitus, and 8 (5%) had an intermediate disorder. Stress hyperglycemia was observed in 10 patients (11%) free from glucose abnormalities. Among the patients without hystory of diabete mellitus and with hyperglycemia on admission, 53% were authentic diabetics. The IV insulin April 02 nd , Thursday 2015 Introduction and Objectives: Little attention has been given to the effect of vascular access site on mortality, while an increasing body of evidence is showing that radial access has much more benefit than femoral access for STsegment elevation myocardial infarction patients. We aimed to assess the influence of vascular access site on mortality at 30 days and at 1 year in STsegment elevation myocardial infarction patients.
Methods:
We included all patients with ST-segment elevation myocardial infarction who had undergone angioplasty at military hospitals of Constantine and Algiers and the hospital of erriadh (ESH erriadh) between 2010 and 2013. We performed 2 multivariate regression models for each endpoint (30-day and 1-year mortality). The only difference between these models was the inclusion or not of the vascular access site (femoral vs radial). We also tested the interaction between hemodynamic instability and vascular access.
Introduction and Objectives:
Little is known about how prognosis is influenced by readmission for acute heart failure (AHF) following non-STsegment elevation acute coronary syndrome (NSTEACS). The aim of this study was to determine the prognostic effect of a first admission for AHF on the risk of acute myocardial infarction (AMI) or death in patients who survived an episode of high-risk NSTEACS.
Methods:
The study involved 342 consecutive patients with high-risk NSTEACS who survived after hospital admission in military hospital of Algiers and Constantine. Readmission for AHF was selected as the main exposure variable, and its association with subsequent AMI or all-cause death was assessed using Cox proportional hazards models for time-dependent covariates that also included adjustment for competing risks. Introduction: Decreased glomerular filtration rate (GFR) is associated with an increased risk of cardiovascular events following acute ST elevation myocardial infarction (STEMI). However, patients with chronic kidney disease have more comorbidities and will receive fewer evidence-based therapies
In a prospective STEMI patient cohort we assessed the effect of an optimal therapeutic management (OTM) according to GFR categories on long-term all-cause mortality.
In a single tertiary referral center, 1,199 patients admitted for acute STEMI were enrolled between 2007 and 2011. We classified patients into 4 categories according to estimated GFR, <45, 45 to 60, 60 to 90, and >90mL/min/1,73m2 with the Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) equation. Optimal therapeutic management was defined as a combination of reperfusion within 12 hours of symptom onset, primary percutaneous coronary intervention (PCI), double anti-platelet regimen, angiotensin converting enzyme inhibitors, statins, beta blockers, and antialdosterone treatment (if left ventricle ejection fraction <40%) upon discharge. The effect of OTM on survival according to GFR categories was analysed in a multivariate survival model including other risk factors and using a propensity score method. Long-term mortality was the principal endpoint.
Results: Patients were followed-up for a median of 4.7 years and 148(12.3%) patients died. OTM was applied in 431 (39.1%) patients of our cohort and overall, was associated with a significantly lower mortality (HR of 0.43 [95% CI, 0.26-0.70; P<0.001). There was a significant mortality reduction in the OTM group compared to the non-OTM group that tended to increase with increasing levels of renal dysfunction (HR of 0.28 [95% CI, 0.13-0.61] in the eGFR<60ml/min patient subgroup; P=0.001) (Figure 1 ).
Conclusions:
OTM lowers long-term mortality whatever the eGFR category and with a trend towards increased efficiency with increasing levels of renal dysfunction.
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